KRN7000 in Treating Patients With Solid Tumors

Summary

RATIONALE: Biological therapies such as KRN7000 use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of KRN7000 in treating patients who have solid tumors that have not responded to previous treatment.

Timeline

Start

1998-09

Primary completion

—

Completion

—

Drugs

Indications